Jui Hsun Chen
Directeur/Membre du Conseil chez WELGENE BIOTECH CO.,LTD.
Profil
Jui Hsun Chen is an Independent Director at TSH Biopharm Corp., Ltd.
and Welgene Biotech Co., Ltd.
She was previously the General Manager, Director & Spokesman at TAHO Pharmaceuticals Ltd.
She completed her undergraduate degree at National Taiwan Normal University and her MBA at Columbia Business School.
Postes actifs de Jui Hsun Chen
| Sociétés | Poste | Début |
|---|---|---|
| WELGENE BIOTECH CO.,LTD. | Directeur/Membre du Conseil | 12/12/2017 |
| TSH BIOPHARM CORPORATION LIMITED | Directeur/Membre du Conseil | 15/06/2018 |
Anciens postes connus de Jui Hsun Chen
| Sociétés | Poste | Fin |
|---|---|---|
| TAHO PHARMACEUTICALS LTD | Directeur Général | - |
Formation de Jui Hsun Chen
| National Taiwan Normal University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WELGENE BIOTECH CO.,LTD. | Health Technology |
| TSH BIOPHARM CORPORATION LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
TAHO Pharmaceuticals Ltd.
 TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan. | Health Technology |
